The core technical team consists of PHDS, university professors and industry experts in the fields of synthetic biology, pharmaceuticals and engineering.

The team has presided over or undertaken more than 10 projects of synthetic biology and recombinant drug industrialization, and has rich experience in drug development and industrialization.

45% of the team has a master's degree or above.